Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis
Arthritis & Rheumatology · 2025
DOI: 10.1002/art.43028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Rongliang Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SA…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Osteocytes, Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 2020 Rising Star Award, American Society for Bone and Mineral Research, Area of Excellence, University Grants Committee, Hong Kong SAR, Start-up Fund, The Chinese University of Hong Kong, Hong Kong SAR.
Abstract (Originalsprache)
Objective
Emerging evidence suggests long noncoding RNA H19 is associated with osteoarthritis (OA) pathology. However, how H19 contributes to OA has not been reported. This study aims to investigate the biologic function of H19 in OA subchondral bone remodeling and OA progression.
Methods
Clinical joint samples and OA animal models induced by surgical destabilization of the medial meniscus (DMM) were used to verify the causal relationship between osteocyte H19 and OA subchondral bone and cartilage changes. MLO‐Y4 osteocyte cells subjected to fluid shear stress were used to verify the mechanism underlying H19‐mediated mechanoresponse. Finally, the antisense oligonucleotide (ASO) against H19 was delivered to mice knee joints by magnetic metal–organic framework (MMOF) nanoparticles to develop a site‐specific delivery method for targeting osteocyte H19 for OA treatment.
Results
Both clinical OA subchondral bone and wildtype mice with DMM‐induced OA exhibit aberrant higher subchondral bone mass, with more H19 mice expressing osteocytes. On the contrary, mice with osteocyte‐specific deletion of H19 are less vulnerable to DMM‐induced OA phenotype. In MLO‐Y4 cells, H19‐mediated osteocyte mechanoresponse through PI3K/AKT/GSK3 signal activation by EZH2‐induced H3K27me3 regulation on protein phosphatase 2A inhibition. Targeted inhibition of H19 (using ASO‐loaded MMOF) substantially alleviates subchondral bone remodeling and OA phenotype.
Conclusion
In summary, our results provide new evidence that the elevated H19 expression in osteocytes may contribute to aberrant subchondral bone remodeling and OA progression. H19 appears to be required for the osteocyte response to mechanical stimulation, and targeting H19 represents a new promising approach for OA treatment. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, The Chinese Univer…
- Department of Physics, Department of Materials Science and Engineering, Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR, China.
- Department of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China, and Li Ka Shing Institute of Health Sciences, The Chinese Un…
- Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China, and Key Laboratory for Regenerative Medicine, Ministry of Education, School of Biomedical Sc…
- Center for Neuromusculoskeletal Restorative Medicine, CUHK InnoHK Centres, Hong Kong Science Park, Hong Kong SAR, China; Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, S…
- Department of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China, and SH Ho Scoliosis Research Laboratory, Joint Scoliosis Res…
ORCID-Profile: Gang Li, Wayne Yuk Wai Lee
Förderung
- 2020 Rising Star Award, American Society for Bone and Mineral Research
- Area of Excellence, University Grants Committee, Hong Kong SAR
- Start-up Fund, The Chinese University of Hong Kong, Hong Kong SAR
- Matching Grant Scheme, University Grants Committee, Hong Kong SAR
- General Research Fund, University Grants Committee, Hong Kong SAR
- Center for Neuromusculoskeletal Restorative Medicine, Health@InnoHK Program, Innovation Technology Commission, Hong Kong SAR
Zitieren
APA
Wang, R., Mehrjou, B., Dehghan-Banian, D., Wang, B. Y. H., Li, Q., Deng, S., Liu, C., Zhang, Z., Zhu, Y., Wang, H., Li, D., Lu, X., Cheng, J. C. Y., Ong, M. T. Y., Chan, H. F., Li, G., Chu, P. K., & Lee, W. Y. W. (2025). Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43028
Vancouver
Wang R, Mehrjou B, Dehghan-Banian D, Wang BYH, Li Q, Deng S, et al. Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43028
BibTeX
@article{Wang2025,
author = {Wang, Rongliang and Mehrjou, Babak and Dehghan-Banian, Dorsa and Wang, Belle Yu Hsuan and Li, Qiangqiang and Deng, Shuai and Liu, Chuanhai and Zhang, Zhe and Zhu, Yanlun and Wang, Haixing and Li, Dan and Lu, Xiaomin and Cheng, Jack Chun Yiu and Ong, Michael Tim Yun and Chan, Hon Fai and Li, Gang and Chu, Paul K and Lee, Wayne Yuk Wai},
title = {Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis},
journal = {Arthritis & Rheumatology},
year = {2025},
doi = {10.1002/art.43028}
}
EUVIMED